A default method to specify skeletons for Bayesian model averaging continual reassessment method for phase I clinical trials (Q7002164)
From MaRDI portal
!
This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use the normal view instead:
scientific article; zbMATH DE number 8022561
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | A default method to specify skeletons for Bayesian model averaging continual reassessment method for phase I clinical trials |
scientific article; zbMATH DE number 8022561 |
Statements
A default method to specify skeletons for Bayesian model averaging continual reassessment method for phase I clinical trials (English)
0 references
4 April 2025
0 references
Bayesian adaptive design
0 references
BMA-CRM
0 references
continual reassessment method
0 references
maximum tolerated dose
0 references
skeleton specification
0 references
0 references
0 references
